Citations

Showing 10 of 108152 citations.

Reply to Wand et al. : Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale
Bourdin, Arnaud , Suehs, Carey , Colby, Thomas V. , Vachier, Isabelle , Molinari, Nicolas , Romagnoli, Micaela , Suehs, Carey M , Vachier, Isabelle , Molinari, Nicolas , Bourdin, Arnaud

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | September 19, 2019 | Volume: 201 | Issue: 2 | Pages: 260-261

10.1164/rccm.201909-1736le | PMID 31535900 Get It

Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations
Kumar, Varun , Naraparaju, Vamsidhar , Sharma, Purnima , Arora, Shilpkumar , Wojtaszek, Ewelina , Gopalan, Radha , Siontis, Konstantinos C. , Deshmukh, Abhishek , Tripathi, Byomesh , Atti, Varunsiri , Gersh, Bernard J.

Mayo Clinic

Journal of the American Heart Association | September 19, 2019 | Volume: 8 | Issue: 19 | Pages: No page available

10.1161/jaha.119.013026 | PMID 31533511 Get It

Background Atrial fibrillation is the most common arrhythmia worldwide. Data regarding 30‐day readmission rates after discharge for atrial fibrillation remain poorly reported. Methods and Results The Nationwide Readmission Database (2010–2014) was queried using the International Classification of Diseases, Ninth Revision ( ICD‐9 ) codes to identify study population. Incidence, etiologies of 30‐day readmission and predictors of 30‐day readmissions, and cost of care were analyzed. Among 1 723 378 patients who survived to discharge, 249 343 (14.4%) patients were readmitted within 30 days. Compared with the readmitted group, the nonreadmitted group had higher utilization of electrical cardioversion and catheter ablation. Atrial fibrillation was the most common cause of readmission (24.1%). Median time to 30‐day readmission was 13 days. Advancing age, female sex, and longer stay during index hospitalization predicted higher 30‐day readmissions, whereas private insurance, electrical cardioversion, catheter ablation, higher income, and elective admissions correlated with lower 30‐day readmission. Comorbidities such as heart failure, neurological disorder, chronic obstructive pulmonary disease, diabetes mellitus, chronic kidney disease, chronic liver failure, coagulopathy, anemia, peripheral vascular disease, and electrolyte disturbance, correlated with increased 30‐day readmissions and cost burden. Trend analysis showed a progressive decline in 30‐day readmission rates from 14.7% in 2010 to 14.3% in 2014 ( P trend, <0.001). Conclusions Approximately 1 in 7 patients were readmitted within 30 days of discharge, with symptomatic atrial fibrillation being the most common cause. We identified a predictive model for increased risk of readmissions and treatment expense. Electrical cardioversion during index admission was associated with a significant reduction in 30‐day readmissions and service charges. The 30‐day readmissions correlated with a substantial rise in the cost of care.
Cuirass Ventilation: An Alternative Home-Based Modality for Chronic Respiratory Failure
Onweni, Chidinma, Goswami, Rachna, Treece, Jennifer, Shipley, Lindsey C., Souza, Randal De , Simberloff, Tander , Baumrucker, Steven J. , Rashid, Saima, O'Neill, Luke A.J.

Mayo Clinic

Home Health Care Management & Practice | September 19, 2019 | Volume: 32 | Issue: 1 | Pages: 40-44

10.1177/1084822319875111 Get It

The biphasic cuirass ventilation (BCV) device is an alternative respiratory support device for patients with chronic respiratory failure. Considered by some a “forgotten” mode of supportive ventilation, the device is portable, lightweight, and easy to operate. Biphasic cuirass ventilation can also be used to rapidly resuscitate patients in acute respiratory distress and requires minimal technical skill to operate. Biphasic cuirass ventilation can be employed by the patient’s caregiver in the home setting, making it a viable alternative to other forms of mechanical ventilation (e.g., BiPAP) for patients enrolled in home hospice or palliative care. The article reviews current knowledge and aims to enhance awareness and encourage further study about cuirass ventilation, particularly with regard to its use in treating patients in the palliative care setting and in the home.
Primary neuroendocrine carcinoma of the brain
Reed, Clay T. , Duma, Narjust , Hálfdánarson, Þorvarður R. , Buckner, Jan C. , Halfdanarson, Thorvardur, Buckner, Jan, Halfdanarson, Thorvardur R

Mayo Clinic

BMJ Case Reports | September 19, 2019 | Volume: 12 | Issue: 9 | Pages: e230582

10.1136/bcr-2019-230582 | PMID 31537610 Get It

Neuroendocrine neoplasms (NENs) are malignancies with rare reports of central nervous system development. A 34-year-old woman was found to have a primary NEN of the brain, and she had recurrence with identical histology 10 years later. Extracranial NENs were excluded. She had routine surveillance for the first 5 years with MRIs and positron emission tomography/CTs after the initial presentation which was treated with radiation followed by cisplatin and etoposide. This case highlights the difference in primary NENs versus NEN metastases to the brain, and that longer periods of surveillance are likely required for primary NENs. This is important because the prognosis between primary NENs and metastatic NENs to the brain are vastly different and should not be treated as equal diseases. The patient eventually died of her recurrence secondary to complications of a ventriculoperitoneal shunt placed for treatment of hydrocephalus from the disease.
A Pilot Study of Wet Lung Using Lung Ultrasound Surface Wave Elastography in an Ex Vivo Swine Lung Model
Zhang, Alex X. , Zhou, Boran , Zhang, Xiaoming

Mayo Clinic

Applied Sciences | September 19, 2019 | Volume: 9 | Issue: 18 | Pages: 3923

10.3390/app9183923 | PMID 36016765 Get It

Extravascular lung water (EVLW) is a basic symptom of congestive heart failure and other conditions. Computed tomography (CT) is standard method used to assess EVLW, but it requires ionizing radiation and radiology facilities. Lung ultrasound reverberation artifacts called B-lines have been used to assess EVLW. However, analysis of B-line artifacts depends on expert interpretation and is subjective. Lung ultrasound surface wave elastography (LUSWE) was developed to measure lung surface wave speed. This pilot study aimed at measureing lung surface wave speed due to lung water in an ex vivo swine lung model. The surface wave speeds of a fresh ex vivo swine lung were measured at 100 Hz, 200 Hz, 300 Hz, and 400 Hz. An amount of water was then filled into the lung through its trachea. Ultrasound imaging was used to guide the water filling until significant changes were visible on the imaging. The lung surface wave speeds were measured again. It was found that the lung surface wave speed increases with frequency and decreases with water volume. These findings are confirmed by experimental results on an additional ex vivo swine lung sample.
Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer
Kasi, Pashtoon Murtaza , Koep, Tyler, Schnettler, Erica, Shahjehan, Faisal , Kamatham, Vaishnavi, Baldeo, Candice , Hughes, Caren, Hughes, Caren L, Kasi, Pashtoon Murtaza

Mayo Clinic

Technology in Cancer Research & Treatment | September 19, 2019 | Volume: 18 | Issue: No issue available | Pages: No page available

10.1177/1533033819873924 | PMID 31533552 Get It

Introduction: Pharmacogenomics is about selecting the “right drug in the right amount for the right patient.” In metastatic colorectal cancer, germline pharmacogenomics testing presents a unique opportunity to improve outcomes, since the genes dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase metabolizing the chemotherapy drugs, 5-fluorouracil, and irinotecan are already well known. In a retrospective analysis of the landmark TRIBE clinical trial [(TRIBE - TRIplet plus BEvacizumab multicenter, phase III trial by the Italian Cooperative GONO (Gruppo Oncologico Nord Ovest) group (NCT00719797)], the proportion of patients with serious adverse events was higher in those with dihydropyrimidine dehydrogenase/UDP-glucuronosyltransferase aberrations and was dose dependent. We aimed to report on the feasibility and the results of incorporating pharmacogenomics testing into clinical practice. Methods: As a quality improvement initiative and a center of individualized medicine grant, we integrated the use of OneOme RightMed comprehensive test, which reports on 27 genes related to pharmacogenomics and over 300 medications of interest. We limited initial testing to patients with colorectal cancer. Pharmacists provided dosage recommendations based on test results in real-time. Results: At our cancer center, 155 patients underwent pharmacogenomics testing from November 2017 to January 2019. Results were available within 3 to 5 days of testing for most patients and were integrated into treatment decision-making. Of 155 sampled participants, a total of 89 (57.4%) participants had an UGT1A1 variant genotype, NM_000463.2: c.-53_-52[8] *1/*28, n = 74 (47.7%); *28/*28, n = 15 (9.7%). Additionally, 4 (2.6%) participants were heterozygous for dihydropyrimidine dehydrogenase. Two (1.3%) individuals were heterozygous for both UDP-glucuronosyltransferase and dihydropyrimidine dehydrogenase genes. All (100%) the patients had at least 1 actionable aberration related to supportive care medications ( CYP-family) of all the possible medications listed on their pharmacogenomics report. Conclusion: Preemptive comprehensive pharmacogenomics testing can be integrated into clinical practice in real-time for patients with cancer given faster turnaround and low cost. Pharmacist-driven, patient-specific medication management consults add further value given the number of genes/drugs. This sets the stage for a prospective randomized clinical trial to demonstrate the amount of benefit this can result in these patients.
Exclusive use of PowerFlow ports may not be appropriate for all patients
Boshell, Michael N., Adamski, Jill , Pham, Huy P. , Guillory, Bryan, Sikora, James , Lisby, Stephanie, Lovingood, Ashley, Zheng, Xuemei , Williams, Lance A , Pham, Huy P , Marques, Marisa B.

Mayo Clinic

Journal of Clinical Apheresis | September 18, 2019 | Volume: 35 | Issue: 1 | Pages: 66-68

10.1002/jca.21749 | PMID 31532839 Get It

Diagnostic and Predictive Value of Speckle Tracking Echocardiography in Cardiac Sarcoidosis
Bruno, Giulia , Calle, Maria Arciniegas, Acharya, Gayatri , Fussner, Lynn M., Ungprasert, Patompong , Blauwet, Lori A., Porquera, Eva Carmona, Villarraga, Hector R. , Stefano, Cristina Di , Cooper, Leslie T. , Ryu, Jay H. , Pellikka, Patricia A.

Mayo Clinic

No container title available | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.14614/v1 Get It

Abstract Background: Sarcoidosis is a systemic granulomatous disease that may affect the myocardium. This study evaluated the diagnostic and prognostic value of 2-dimensional speckle tracking echocardiography in cardiac sarcoidosis (CS). Methods: Eighty-three patients with extracardiac, biopsy-proven sarcoidosis and definite/probable diagnosis of cardiac involvement diagnosed from January 2005 through December 2016 were included. In order to analyze the alteration of strain parameters in early stages of CS, a subgroup of 23 CS patients with left ventricular ejection fraction (LVEF) within normal limits (LVEF>52% for men: >54% for women, mean value: 57.3%±3.8%) and no wall motion abnormalities was compared with 97 controls (1:4) without cardiac disease. LV and right ventricular (RV) global longitudinal (GLS), circumferential (GCS), and radial (GRS) strain and strain rate (SR) analyses were performed with TomTec software and correlated with cardiac outcomes (including heart failure and arrhythmias). This study was approved by the Mayo Clinic Institutional Review Board, and all patients gave informed written consent to participate. Results: Mean age of CS patients was 53.6±10.8 years, and 34.9% were women. Mean LVEF was 43.2%±12.4%; LV GLS, -12.4%±3.7%; LV GCS, -17.1%±6.5%; LV GRS, 29.3%±12.8%; and RV wall GLS, 14.6%±6.3%. In the 23 patients with early stage CS with normal LVEF and RV systolic function, strain parameters were significantly reduced when compared with controls (respectively: LV GLS, -15.9%±2.5% vs -18.2%±2.7% [ P =.001]; RV GLS, -16.9%±4.5% vs -24.1%±4.0% [ P <.001]). A LV GLS value of -16.3% provided 82.2% sensitivity and 81.2% specificity for the diagnosis of CS (AUC 0.91), while a RV value of -19.9% provided 88.1% sensitivity and 86.7% specificity (AUC 0.93). Hospital admission and heart failure significantly correlated to impaired LV GLS (> -14%). Conclusion: Reduced strain values in the LV GLS and RV GLS can be used in the diagnostic algorithm in patients with suspicion of cardiac sarcoidosis. These values also correlate with adverse cardiovascular events.
Identifying asymptomatic Leishmania infections in non-endemic villages in Gedaref state, Sudan.
Mohamed, Nouh Saad , Ahmed, Ayman, Mohammed, Anwar O., Ali, Mohamed Siralkhatim , Elaagip, Arwa , Mohamed, Nouh Saad , Osman, Hussam Ali , Muneer, Mohamed S. , Samy, Abdallah M , Siddig, Emmanuel Edwar , Hamid, Muzamil Mahdi Abdel , Omer, Rihab A.

Mayo Clinic

No container title available | September 18, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.11134/v3 Get It

Abstract Objectives: Infection with the causative agent of visceral leishmaniasis (VL) may be either symptomatic or asymptomatic. In this study we aimed at investigating the prevalence of asymptomatic infections of leishmania in non-endemic villages in Gedaref state, Sudan. A descriptive cross-sectional study conducted during September and October 2014. Blood samples were collected for serological and molecular analysis. Sticky-traps, knockdown spray and CDC-miniature light traps were used for the collection of sandflies. Results: Ninety-Five participants were included; 52 from Abukishma, 15 Algadamblia Tirfa, 25 Abualnaja and 3 were from Algadamblia Aljabal . Females constituted 56 (58.9%) of the study participants while males were 39 (41.1%). The most frequent age group was >40-years (54.7%). Balanites/Acacia trees were the most planted tree inside the houses; 78 (82.1%). Also, 85 (89.5%) of the participants breed animals inside the house. DAT test revealed 5 positive participants (5.2%). 4/5 DAT positive were past VL infection. PCR detected 35 (36.8%) positive participants. A total of 31/35 was considered asymptomatic infections based on PCR. Households planted Balanites/Acacia trees or breed domestic animals were found in high percentages with L. donovani PCR positive participants (60.1%, 91.4%). No statistically significant was found for VL associated risk factors and VL asymptomatic participants.